These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9672052)

  • 1. Does participation in psychosocial treatment augment the benefit of clozapine? Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Tekell J; Peters J; Cramer J; Fontana A; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1998 Jul; 55(7):618-25. PubMed ID: 9672052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D
    N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Lawson W; Crayton J; Cramer J; Xu W; Thomas J; Stolar M; Charney D
    Biol Psychiatry; 1998 Sep; 44(6):475-82. PubMed ID: 9777179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Dunn L; Peszke M; Cramer J; Xu W; Thomas J; Charney D
    Am J Psychiatry; 1999 Jan; 156(1):88-93. PubMed ID: 9892302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of clozapine in patients with high and low levels of hospital use. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Allan E; Erdos J; Frisman LK; Xu W; Thomas J; Henderson W; Charney D
    Arch Gen Psychiatry; 1999 Jun; 56(6):565-72. PubMed ID: 10359474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia.
    Rosenheck R; Evans D; Herz L; Cramer J; Xu W; Thomas J; Henderson W; Charney D
    Schizophr Bull; 1999; 25(4):709-19. PubMed ID: 10667741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia. The Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.
    Rosenheck R; Cramer J; Jurgis G; Perlick D; Xu W; Thomas J; Henderson W; Charney D
    J Clin Psychiatry; 2000 Sep; 61(9):671-6. PubMed ID: 11030488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrete state analysis for interpretation of data from clinical trials.
    Sugar CA; James GM; Lenert LA; Rosenheck RA
    Med Care; 2004 Feb; 42(2):183-96. PubMed ID: 14734956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome.
    Buchanan RW; Breier A; Kirkpatrick B; Ball P; Carpenter WT
    Am J Psychiatry; 1998 Jun; 155(6):751-60. PubMed ID: 9619146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of clozapine on completed suicide.
    Sernyak MJ; Desai R; Stolar M; Rosenheck R
    Am J Psychiatry; 2001 Jun; 158(6):931-7. PubMed ID: 11384902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals.
    Essock SM; Frisman LK; Covell NH; Hargreaves WA
    Arch Gen Psychiatry; 2000 Oct; 57(10):987-94. PubMed ID: 11015817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics.
    Potkin SG; Fleming K; Jin Y; Gulasekaram B
    J Clin Psychopharmacol; 2001 Oct; 21(5):479-83. PubMed ID: 11593072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
    Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
    J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing environments and alternative perspectives in evaluating the cost-effectiveness of new antipsychotic drugs.
    Rosenheck R; Doyle J; Leslie D; Fontana A
    Schizophr Bull; 2003; 29(1):81-93. PubMed ID: 12908663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational Characteristics of Veterans Affairs Clinics With High and Low Utilization of Clozapine.
    Gören JL; Rose AJ; Engle RL; Smith EG; Christopher ML; Rickles NM; Semla TP; McCullough MB
    Psychiatr Serv; 2016 Nov; 67(11):1189-1196. PubMed ID: 27301765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.